EQS-News

Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals - Seite 2

Furthermore, the shareholders approved the proposal to create authorized share capital in the nominal amount of CHF 31,579,080, corresponding to 10 per cent of the registered share capital, and to increase the conditional share capital for financing, acquisitions and other purposes to CHF 31,579,080. At the same time, the shareholders resolved to include a provision in the Articles of Association pursuant to which the total number of shares that may be issued from authorized and conditional share capital is limited to a total of 10 per cent of the current registered share capital (corresponding to 1,052,636 registered shares).

Likewise, the shareholders resolved an amendment to the Articles of Association granting the Board of Directors flexibility with respect to the designation of the Compensation Committee.

The minutes with the detailed voting results will be available at "zurrosegroup.com > Investors & Media > Annual General Meeting" as of 30 April 2021.

Investors and analyst contact
Christoph Herrmann, Head of Investor Relations
Email: [e-mail], phone: [phone]

Media contact
Lisa Lüthi, Head of Group Communications
Email: [e-mail], phone: [phone]

Agenda
A Capital Markets Day in virtual format will take place on 16 June 2021. Invitation and agenda will follow at a later date.

18 August 2021 Half-Year Results
21 October 2021 Q3 Trading Update

Zur Rose Group

The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. It also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany's best-known pharmacy brand, DocMorris, and employs more than 2,200 people at sites in Switzerland, Germany, the Netherlands, Spain and France. Now serving more than 11 million active customers in core European markets, Zur Rose generated revenue of CHF 1,752 million (including external revenue) in 2020.